Products

DeepXray Spina
Alpha Intelligence Manifolds, Inc.
Clinical Decision Support & Reference
DeepXray Spina is an AI-assisted diagnosis system using X-rays for precision diagnosis and automated monitoring of osteoporosis. It helps clinicians identify bone health issues such as osteoporosis by analyzing medical images to detect low bone mineral density.
DeepXray
Alpha Intelligence Manifolds, Inc.
Clinical Decision Support & Reference
DeepXray by Alpha Intelligence Manifolds is an AI-powered software for analyzing X-rays to detect and monitor osteoarthritis and osteoporosis, providing automated measurements, disease assessment, and interactive reports for medical professionals.

See all 2 products →

About Alpha Intelligence Manifolds

Alpha Intelligence Manifolds (AIM) is a healthcare AI company focused on providing affordable and accessible precision care for prevalent chronic diseases, particularly within an aging global population. The company leverages AI and data analytics to enhance early preventive detection, precision diagnosis, and automated monitoring of conditions like cardiovascular diseases and chronic bone diseases (e.g., osteoporosis and osteoarthritis).

AIM’s solutions aim to overcome the high cost and complexity of existing precision care devices. They utilize widely available imaging modalities such as X-rays and ultrasound for large-scale deployment at points-of-care. Their flagship products, DeepXray™ and DeepSono™, are AI-powered image analysis solutions designed to streamline workflows and generate instant AI reports, assisting clinical professionals like radiologists, orthopedists, and medical technicians. For instance, DeepXray™ assists in analyzing and measuring radiographic abnormalities for knee osteoarthritis and provides AI-assisted diagnosis and monitoring for osteoporosis, including BMD estimation and T-score/Z-score conversion.

AIM’s technology has received regulatory approvals in several regions, including the US FDA, Japan PMDA, Taiwan FDA, Thailand FDA, and Vietnam MoH, demonstrating their commitment to international standards and market expansion. The company emphasizes a “zero-click” fully automated workflow for medical image analysis, aiming for a tenfold increase in efficiency and a tenfold reduction in cost compared to traditional diagnostic processes.

Focus Areas

early preventive detection precision diagnosis automated monitoring chronic diseases cardiovascular diseases chronic bone diseases osteoporosis osteoarthritis medical imaging AI X-ray analysis ultrasound analysis

Business Intelligence

TechnologyAI-inside medical image server platform, Docker containers on a Linux server, computer vision and AI algorithms, DICOM service, "Zero-Click" instant AI report generation

What Physicians Need to Know

Early Preventive Detection
Alpha Intelligence Manifolds (AIM) focuses on affordable and accessible early preventive detection of chronic diseases, particularly cardiovascular and chronic bone diseases like osteoporosis and osteoarthritis. Their AI-powered solutions aim to identify risks before severe symptoms develop.
Precision Diagnosis
AIM offers AI-assisted diagnosis systems, such as DeepXray™ Genu for osteoarthritis and DeepXray™ Coxa/Spina for osteoporosis, which utilize X-rays for precision diagnosis. These systems provide objective and quantitative diagnostic results, including disease severity, joint space narrowing, osteophyte, and sclerosis assessments.
Automated Monitoring
The company specializes in automated monitoring of chronic disease progression, offering tools that track changes over time with high consistency, addressing a key pain point in chronic disease management.
Chronic Bone Diseases (Osteoporosis & Osteoarthritis)
AIM has a strong focus on chronic bone diseases, with FDA-cleared AI-assisted diagnosis systems for osteoporosis (DeepXray™ Coxa and DeepXray™ Spina) and osteoarthritis (DeepXray™ Genu). These tools provide fast screening, automated progression monitoring, and high accuracy that can rival traditional methods like DXA for osteoporosis.
Cardiovascular Diseases
AIM addresses cardiovascular diseases through early preventive detection and precision diagnosis, leveraging AI and data analytics to provide affordable and accessible care. Their DeepSono™ CardioX performs direct video inference for instant myocardial contouring and precise ejection fraction assessment.
Medical Imaging AI (X-ray & Ultrasound Analysis)
The core of AIM's technology lies in medical imaging AI, specifically X-ray and ultrasound analysis. Their DeepXray™ products transform conventional X-ray modalities into smart ones, providing AI reports in as little as one minute. DeepSono™ CardioX is their ultrasound analysis solution.
Physician Tip

Alpha Intelligence Manifolds' solutions offer physicians enhanced efficiency and accuracy in diagnosing and monitoring chronic bone and cardiovascular diseases. The AI-assisted X-ray analysis for osteoporosis and osteoarthritis can provide rapid, objective, and quantitative reports, potentially improving diagnostic consistency and reducing the burden on specialists. The automated monitoring capabilities can help track disease progression more effectively, supporting better patient management and adherence to treatment plans. The visualized diagnostic results can also serve as a valuable tool for patient communication and education, reinforcing patient awareness and motivation for compliance. For cardiovascular conditions, DeepSono™ CardioX offers instant myocardial contouring for precise ejection fraction assessment, streamlining cardiac evaluations. These tools can be particularly beneficial for junior or non-specialty clinicians by improving diagnostic ability and consistency.

Alpha Intelligence Manifolds offers DeepPACS, a seamless medical image AI service platform with standard DICOM service, enabling streamlined workflows and 'Zero-Click' instant AI report generation. This suggests their solutions are designed to integrate with existing Picture Archiving and Communication Systems (PACS) in clinics and hospitals, facilitating easy adoption and enhancing current medical imaging infrastructure.

Products by Alpha Intelligence Manifolds

2 products in the directory

DeepXray Spina
Alpha Intelligence Manifolds, Inc.
Clinical Decision Support & Reference
DeepXray Spina is an AI-assisted diagnosis system using X-rays for precision diagnosis and automated monitoring of osteoporosis. It helps clinicians identify bone health issues such as osteoporosis by analyzing medical images to detect low bone mineral density.
DeepXray
Alpha Intelligence Manifolds, Inc.
Clinical Decision Support & Reference
DeepXray by Alpha Intelligence Manifolds is an AI-powered software for analyzing X-rays to detect and monitor osteoarthritis and osteoporosis, providing automated measurements, disease assessment, and interactive reports for medical professionals.

What the Web Says

Alpha Intelligence Manifolds (AIM) is a company focused on affordable and accessible early preventive detection, precision diagnosis, and automated prognosis monitoring of chronic diseases, particularly osteoporosis. They aim to achieve 10x efficiency and 1/10 cost compared to existing diagnostic processes. Their product, DeepXray™, is an AI-powered solution for osteoporosis screening and diagnosis. The company has received FDA clearance for at least one product.

Overall: Mixed

Strengths

  • Focus on affordable and accessible early preventive detection and diagnosis of chronic diseases.
  • Aims for significant efficiency improvements (10x) and cost reduction (1/10) in diagnostics.
  • DeepXray™ product utilizes AI for osteoporosis screening and diagnosis.
  • FDA clearance for at least one product indicates regulatory compliance.
  • Addresses a critical pain point in healthcare regarding efficient and accurate early diagnosis of osteoporosis.

Limitations

  • Limited public reviews available on major platforms like G2, Glassdoor, Capterra, and Reddit specifically for "Alpha Intelligence Manifolds."
  • Information on company culture, salaries, and work-life balance is not readily available under this specific company name.
  • Some search results for "Alpha" or "Manifolds" alone are not directly relevant to "Alpha Intelligence Manifolds."
  • Lack of detailed product reviews from healthcare IT reviewers beyond general mentions of AI in fracture detection.

Based on reviews from: Google Search, Alpha Intelligence Manifolds Website, accessdata.fda.gov, NIAMSfunded (National Institute of Arthritis and Musculoskeletal and Skin Diseases)

Last updated: 2026-10-15

Videos

News, demos, and interviews about Alpha Intelligence Manifolds.

Loading videos...

Videos load interactively. If none appear, search YouTube for Alpha Intelligence Manifolds →

View all on YouTube

Press & Coverage

Alpha Intelligence Manifolds, Inc. Publications
Comprehensive opportunistic osteoporosis screening with AI: retrospective development and prospective validation of dual-site BMD prediction from a single radiograph.
This publication details the development and validation of an AI system for comprehensive opportunistic osteoporosis screening using a single radiograph to predict dual-site bone mineral density.
2026-07
Alpha Intelligence Manifolds, Inc. News
FDA 認證、頂尖期刊與國際學會三重肯定!采風智匯「DeepXray Spina」強勢叩關紐澳、中東與印太市場
Alpha Intelligence Manifolds' DeepXray™ Spina, an AI-assisted diagnostic system for osteoporosis, has received FDA certification and recognition from top journals and international societies, enabling its entry into markets in Australia, New Zealand, the Middle East, and the Indo-Pacific.
2026-07
Alpha Intelligence Manifolds, Inc. News
從10分鐘到60秒,采風智匯DeepSono 用AI 改寫心衰竭診斷
Alpha Intelligence Manifolds' DeepSono AI-assisted cardiac ultrasound diagnostic system is designed to address the shortage of high-end equipment and cardiac specialists, significantly reducing heart failure diagnosis time from 10 minutes to 60 seconds.
2026-05
Alpha Intelligence Manifolds, Inc. Publications
Artificial intelligence-assisted screening reveals high prevalence of osteoporosis in Vietnamese adults using pelvic and hip radiographs.
This study highlights the effectiveness of AI-assisted screening in identifying a high prevalence of osteoporosis among Vietnamese adults through the analysis of pelvic and hip radiographs.
2026-04
Alpha Intelligence Manifolds, Inc. Publications
AI-derived bone mineral density from standard radiographs compared with DXA for fracture prediction in a 10-year real-world cohort study.
This publication compares AI-derived bone mineral density from standard radiographs with DXA for fracture prediction over a 10-year real-world cohort, demonstrating the potential of AI in this field.
2026-02
Alpha Intelligence Manifolds, Inc. Publications
Osteoporosis prediction from Frontal Lumbar Spine X-rays.
This article focuses on the prediction of osteoporosis using AI analysis of frontal lumbar spine X-rays.
2026-01
Alpha Intelligence Manifolds, Inc. News
采風智匯獲國內外創投基金注資全面啟動AI醫療國際化
Alpha Intelligence Manifolds (AIM) has secured investment from domestic and international venture capital funds, fully launching its AI medical internationalization strategy.
2025-08
Alpha Intelligence Manifolds, Inc. News
DeepXray™ 勇奪日本ITEM2025醫療影像展第2名
Alpha Intelligence Manifolds' DeepXray™ secured second place at the ITEM2025 International Technical Exhibition of Medical Imaging in Japan.
2025-07

Frequently Asked Questions

Alpha Intelligence Manifolds (AIM) offers AI solutions designed to aid in the early preventive detection and automated monitoring of various chronic diseases. For cardiovascular health, our AI can analyze medical imaging and patient data to identify early markers of conditions such as atherosclerosis or heart failure. In chronic bone diseases, our technology focuses on precision diagnosis and progression monitoring for osteoporosis and osteoarthritis through advanced X-ray and ultrasound analysis, helping physicians intervene sooner and tailor treatment plans.
Our medical imaging AI products leverage advanced algorithms to analyze X-ray and ultrasound images with a high degree of precision, often identifying subtle patterns and anomalies that may be difficult for the human eye to detect. This enhances early preventive detection by flagging potential issues sooner, leading to more accurate and timely diagnoses. For conditions like early-stage osteoarthritis or subtle cardiovascular changes, our AI provides quantitative assessments and risk stratification, augmenting the physician's diagnostic capabilities.
Alpha Intelligence Manifolds prioritizes data privacy and adheres strictly to global regulatory compliance standards, including HIPAA, GDPR, and relevant FDA guidelines for medical devices. Our AI solutions are developed with privacy-by-design principles, ensuring all patient data is anonymized and secured. We implement robust cybersecurity measures and undergo regular audits to maintain the highest levels of data protection and regulatory compliance, providing healthcare providers with confidence in our secure and ethical practices.
Alpha Intelligence Manifolds offers flexible pricing models tailored to the specific needs and scale of healthcare organizations, which can include subscription-based licensing or per-study fees. Our comprehensive support package includes initial implementation and integration assistance, ongoing technical support, and continuous software updates. We also provide extensive training programs for physicians and healthcare administrators to ensure seamless adoption and optimal utilization of our AI platforms, maximizing their clinical and operational benefits.
Alpha Intelligence Manifolds is committed to long-term stability and continuous innovation in the healthcare AI sector, backed by strong investor support and a clear product roadmap. We are actively pursuing strategic partnerships with leading healthcare institutions, research organizations, and technology providers to expand our reach and enhance our AI capabilities. Our future product development focuses on integrating new data modalities, expanding our disease coverage, and further refining our AI for even greater precision in early detection, diagnosis, and automated monitoring across a broader spectrum of chronic conditions.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.